- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Cora N. Sternberg, MD, FACP, Clinical Director of the Englander Institute for Precision Medicine, Professor of Medicine, Weill Cornell Medicine, Meyer Cancer Center New York, Presbyterian, NY Alicia Morgans, MD, MPH , Geni...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Mark Fleming, MD, GU Disease Committee Chair, Sarah Connon Research Institute, President, Virginia Oncology Association, Norfolk, VA Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic U...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Rana R. McKay, Medical Oncologist, Associate Professor, University of California, San Diego, San Diego, CA Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at Dana-Farber...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Fred Saad, MD, FRSC, Professor, Department of Surgery, Raymond Garneau Chair in Prostate Cancer, Université de Montréal, Montréal, QC Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: A. Oliver Sartor, MD, Disease Group Leader GU Cancers, Director of Radiopharmaceutical Trials, Mayo Clinic, Rochester, MN Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Hartmann Endowed Chair for Prostate Cancer Research Chair, Genitourinary Multidisciplinary Team, Professor of Oncology and Medicine, Karma...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Sumit K. Subudhi, Associate Professor, Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center,...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC Fred Saad, MD, FRSC, Professor, Department of Surgery, Raymond Garneau Chair in Prostate Cancer, Uni...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Daniel George, MD, Medical Oncologist, Professor, Departments of Medicine and Surgery, Leader, DCI Center for Prostate and Urologic Cancers, Duke Cancer Institute, Duke University, Durham, NC Alicia Morgans, MD, MPH , Geni...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Rana R. McKay, Medical Oncologist, Associate Professor, University of California, San Diego, San Diego, CA Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at Dana-Farbe...
|
